Ira Lubert - Safeguard Scientifics Independent Director
SFEDelisted Stock | USD 0.46 0.19 29.23% |
Director
Mr. Ira M. Lubert is Independent Director of the Company. Ira M. Lubert has served as CoFounder and Chairman of each of LubertAdler Management Company, L.P., which advises a series of real estate funds, and Independence Capital Partners, LLC, which provides services to certain investment advisers. He is also a CoFounder of and a Partner in a series of private equity and real estate fund advisers, including LLR Management, L.P., which focuses on lower middle market growth companies Quaker Partners Management, L.P., which advises a series of life sciences funds LEM Capital, L.P., which advises a series of real estate funds invested primarily in multifamily properties LBC Credit Management, LP, which advises a series of structured finance funds and Patriot Financial Management, L.P., which advises a series of community banking funds. Mr. Lubert has also served as a CoFounder of Versa Capital Management, LLC, specializing in distressed and special situations and worked with Rubenstein Partners, L.P., an office real estate investment firm, to found its first fund, Rubenstein Properties Fund, L.P. . Previously, he was a General Partner of Rose Glen Capital Management, LP, a private equity fund. From 1986 to 1997, he was a Managing Director and CoFounder of TL Ventures, the subsequent Safeguardaffiliated family of early stage venture funds with over 1 billion of capital under management. Prior to that, he served as Chairman of the Board and President of CompuCom Systems, a microcomputer reseller. Mr. Lubert currently serves on the Board of Trustees of Pennsylvania State University, where he served as Chairman from July 2016 to July 2017. He had previously served on the Pennsylvania State University Board from 1997 to 2000 and from 2007 to 2013 since 2018.
Age | 67 |
Tenure | 6 years |
Phone | 610-293-0600 |
Web | https://www.safeguard.com |
Safeguard Scientifics Management Efficiency
The company has Return on Asset of (0.0778) % which means that on every $100 spent on assets, it lost $0.0778. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2938) %, meaning that it generated no profit with money invested by stockholders. Safeguard Scientifics' management efficiency ratios could be used to measure how well Safeguard Scientifics manages its routine affairs as well as how well it operates its assets and liabilities.The company has 1.68 M in debt with debt to equity (D/E) ratio of 0.04, which may show that the company is not taking advantage of profits from borrowing. Safeguard Scientifics has a current ratio of 18.08, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Safeguard Scientifics until it has trouble settling it off, either with new capital or with free cash flow. So, Safeguard Scientifics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Safeguard Scientifics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Safeguard to invest in growth at high rates of return. When we think about Safeguard Scientifics' use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | DIRECTOR Age | ||
Price Blackford | Central Securities | 66 | |
David Shaw | Fiera Capital | 63 | |
Nisha Kumar | Western Asset High | 50 | |
Antonio Monari | Azimut Holding SpA | 66 | |
David Gluskin | Mount Logan Capital | N/A | |
Conrad Ciccotello | Tortoise Mlp Closed | 60 | |
Peter Anderson | Flow Capital Corp | N/A | |
Wilhelm Bender | European Equity Closed | 75 | |
Anna Bortolotti | Azimut Holding SpA | 59 | |
Bruce Calvin | Flow Capital Corp | 51 | |
Eldon Smith | Flow Capital Corp | 74 | |
Raymond Laurin | Fiera Capital | N/A | |
Richard Goeltz | Central Europe Russia | 71 | |
Teresa Nicolini | Azimut Holding SpA | 65 | |
Paolo Martini | Azimut Holding SpA | 44 | |
Sylvain Brosseau | Fiera Capital | N/A | |
Catherine Best | Flow Capital Corp | 61 | |
Gerardo Tribuzio | Azimut Holding SpA | 51 | |
Wilhelm Bender | Central Europe Russia | 74 | |
Kenneth Froewiss | Central Europe Russia | 75 | |
Robert Young | Nuveen New Jersey | 57 |
Management Performance
Return On Equity | -0.29 | |||
Return On Asset | -0.0778 |
Safeguard Scientifics Leadership Team
Elected by the shareholders, the Safeguard Scientifics' board of directors comprises two types of representatives: Safeguard Scientifics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Safeguard. The board's role is to monitor Safeguard Scientifics' management team and ensure that shareholders' interests are well served. Safeguard Scientifics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Safeguard Scientifics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Julie Dobson, Independent Director | ||
Ira Lubert, Independent Director | ||
Russell Glass, Independent Director | ||
Matthew Barnard, Secretary Counsel | ||
Mark Herndon, Chief Financial Officer, Senior Vice President | ||
Mark Dow, CFO CEO | ||
David Kille, CFO | ||
Alex Fuiks, Associate | ||
Maureen Morrison, Independent Director | ||
Albert II, Sr. VP and Managing Director of Healthcare | ||
Scott Snyder, Senior Vice President Managing Director, Chief Technology and Innovation Officer | ||
George MacKenzie, Independent Director | ||
Jack Messman, Independent Director | ||
John Shave, Vice President - Business Development and Corporate Communications | ||
Eric Salzman, Chief Restructuring Officer | ||
Stephen Zarrilli, President CEO, Director | ||
Jeffrey McGroarty, CFO, Senior Vice President - Finance | ||
Mark CPA, VP CFO | ||
John Roberts, Independent Director | ||
Robert Rosenthal, Executive Chairman of the Board, Principal Executive Officer | ||
Stephen Fisher, Independent Director | ||
Andrew Lietz, Independent Chairman of the Board | ||
Seth Zuckerman, Associate Healthcare | ||
Brian Sisko, Executive Vice President Managing Director | ||
Mara Aspinall, Director | ||
Joseph Manko, Independent Director |
Safeguard Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Safeguard Scientifics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.29 | |||
Return On Asset | -0.0778 | |||
Current Valuation | (4.6 M) | |||
Shares Outstanding | 16.58 M | |||
Shares Owned By Insiders | 28.01 % | |||
Shares Owned By Institutions | 45.02 % | |||
Number Of Shares Shorted | 208.05 K | |||
Price To Earning | 23.06 X | |||
Price To Book | 0.41 X | |||
EBITDA | (7.36 M) |
Currently Active Assets on Macroaxis
LAAC | Lithium Americas Corp | |
F | Ford Motor | |
CHPT | ChargePoint Holdings | |
AXL | American Axle Manufacturing | |
ICLN | iShares Global Clean |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Safeguard Scientifics information on this page should be used as a complementary analysis to other Safeguard Scientifics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Safeguard Stock
If you are still planning to invest in Safeguard Scientifics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Safeguard Scientifics' history and understand the potential risks before investing.
Stocks Directory Find actively traded stocks across global markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |